Protected carotid stenting in high-surgical-risk patients: The ARCHeR results
William A. Gray(Main Line Health), David J. Cohen(Baim Institute for Clinical Research), L. Nelson Hopkins(The University of Western Australia), Thomas P. Davis(University of Arizona), Alberto Cremonesi(Maria Cecilia Hospital), Gary Walker, Patrick Verta, Renu Virmani(CVPath Institute), Sanjay Yadav(Cleveland Clinic), Mark H. Wholey(University of Pittsburgh), Ronald M. Fairman(University of Pennsylvania), J.J. Popma(Brigham and Women's Hospital), Richard Atkinson(University of California, Davis)
Cited by 411
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
Atherosclerotic Plaque Progression and Vulnerability to Rupture
|Arteriosclerosis Thrombosis and Vascular Biology|2005|1.3k
Pathology of Acute and Chronic Coronary Stenting in Humans
|Circulation|1999|874
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
|New England Journal of Medicine|2017|851